Aesculap has launched valve in the US in partnership with The Christoph Miethke (MIETHKE) for treating hydrocephalus-related headaches.

Hydrocephalus is a condition caused by excessive accumulation of cerebrospinal fluid in the brain. The disorder causes chronic headaches, vomiting, abnormal head enlargement and may even lead to death.

The valve is designed for various forms of hydrocephalus. The device can also be customised to provide optimal therapy to patients.

Aesculap president Chuck DiNardo said: “We are very pleased to be able to continue to provide healthcare teams with new and innovative solutions.

“With our strong partnership with MIETHKE comes an impactful collaborative effort to bring better hydrocephalus solutions to patients such as the new valve.”

Featuring an adjustable gravitational unit and a fixed differential pressure unit, the valve operates in a position-dependent manner.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In combination, the two units ensure automatic adjustment of the opening pressure based on the patient’s body position and reduce the risk of over-drainage complications.

According to the company, the valve is the smallest adjustable gravitational valve currently available in the US market.

MIETHKE founder and CEO Christoph Miethke said: “The patient is our priority and we will continue to invest in research and development to create better solutions.

“Our focus on hydrocephalus valves creates expertise and openness to future developments that allow us to serve in a way that will improve the lives that we touch.”

It is estimated that more than one million people in the US live with hydrocephalus condition, according to the Hydrocephalus Association.